These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis]. Kawahara S, Kamisaka K, Tada A, Nakada H, Mishima Y, Yoshimoto S, Matsuyama T, Kibata M, Nagare J. Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726 [Abstract] [Full Text] [Related]
26. [Prospects for development of new antituberculous drugs]. Tomioka H. Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850 [Abstract] [Full Text] [Related]
31. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492. Harnett SJ, Fraise AP, Andrews JM, Jevons G, Brenwald NP, Wise R. J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651 [Abstract] [Full Text] [Related]